| Lamoille Health Partners Inc. | |
|
272 N Main St Unit 101 Cambridge VT 05444 | |
| (802) 644-5114 | |
| (802) 644-5573 |
| Full Name | Lamoille Health Partners Inc. |
|---|---|
| Speciality | Clinic/Center |
| Location | 272 N Main St, Cambridge, Vermont |
| Authorized Official Name and Position | Stuart May (CEO) |
| Authorized Official Contact | 8028880901 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Lamoille Health Partners Inc. Po Box 749 Morrisville VT 05661-0749 Ph: (802) 851-8600 | Lamoille Health Partners Inc. 272 N Main St Unit 101 Cambridge VT 05444 Ph: (802) 644-5114 |
| NPI Number | 1538945001 |
|---|---|
| Provider Enumeration Date | 08/31/2023 |
| Last Update Date | 08/31/2023 |
| Medicare PECOS PAC ID | 4789586942 |
|---|---|
| Medicare Enrollment ID | O20231108000382 |
News Archive
After decades of studying the pathological process that wipes out large volumes of memory, scientists at The Feinstein Institute for Medical Research discovered a molecule called c-Abl that has a known role in leukemia also has a hand in Alzheimer's disease.
When recommending vitamin D supplements, doctors should look at each individual patient as having different requirements and not rely on "one-size-fits-all" guidelines, according to a study by researchers at Rutgers and the University of California, San Francisco.
Living kidney donors show no increase in their risk of heart attacks or other cardiovascular events in the years after donation, according to the largest-ever study of the issue, being presented at the American Society of Nephrology's 40th Annual Meeting and Scientific Exposition in San Francisco.
Symphogen announced today that Phase 2 data will be presented from an open-label, multi-center clinical trial evaluating the safety and tolerability of rozrolimupab in adult, RhD positive, non-splenectomized patients with Immune thrombocytopenia (ITP) at the 16th Congress of the European Hematology Association meeting in London, UK on June 10 from 5:45 to 7:00 PM.
Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced consolidated results for the second quarter of 2009 and for the six-month period ended June 30, 2009.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538945001 | NPI | - | NPPES |
News Archive
After decades of studying the pathological process that wipes out large volumes of memory, scientists at The Feinstein Institute for Medical Research discovered a molecule called c-Abl that has a known role in leukemia also has a hand in Alzheimer's disease.
When recommending vitamin D supplements, doctors should look at each individual patient as having different requirements and not rely on "one-size-fits-all" guidelines, according to a study by researchers at Rutgers and the University of California, San Francisco.
Living kidney donors show no increase in their risk of heart attacks or other cardiovascular events in the years after donation, according to the largest-ever study of the issue, being presented at the American Society of Nephrology's 40th Annual Meeting and Scientific Exposition in San Francisco.
Symphogen announced today that Phase 2 data will be presented from an open-label, multi-center clinical trial evaluating the safety and tolerability of rozrolimupab in adult, RhD positive, non-splenectomized patients with Immune thrombocytopenia (ITP) at the 16th Congress of the European Hematology Association meeting in London, UK on June 10 from 5:45 to 7:00 PM.
Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced consolidated results for the second quarter of 2009 and for the six-month period ended June 30, 2009.
› Verified 3 days ago
Family Practice Associates Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 272 No Main St, Suite 101, Cambridge, VT 05444 Phone: 802-644-5114 Fax: 802-644-5573 |